UTI - Healthcare Fund
Institution · data to Jun 2026
Disclosed value
₹997 Cr
Jun 2026 closes
At current prices
…
Current holdings
3
Tracked since
Jun 2018
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Global Health Ltd | 2.01% | NEW | ₹731 Cr |
| Marksans Pharma Ltd | 2.11% | 0.38 | ₹252 Cr |
| Laxmi Dental Ltd | 1.09% | NEW | ₹14 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, UTI - Healthcare Fund — an institution tracked through public shareholding filings — disclosed 3 holdings in Indian listed companies worth ₹997 crore. The same holdings-at-filing-value basis put it at ₹939 crore in Mar 2026 (+6.2%). Solomo carries these filings back to Jun 2018.
Largest disclosed positions in Jun 2026: Global Health Ltd (MEDANTA — 2.01% of the company, ₹731 crore); Marksans Pharma Ltd (MARKSANS — 2.11% of the company, ₹252 crore); Laxmi Dental Ltd (LAXMIDENTL — 1.09% of the company, ₹14 crore).
Changes in the Jun 2026 filings: newly disclosed — Global Health Ltd, Laxmi Dental Ltd. Stake reduced in Marksans Pharma Ltd (−0.38 pp). No longer disclosed after the previous quarter: Glenmark Pharmaceuticals Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹997 Cr | +6.2% |
| Mar 2026 | ₹939 Cr | +402.4% |
| Dec 2025 | ₹187 Cr | +31.4% |
| Sep 2025 | ₹142 Cr | −12.8% |
| Jun 2025 | ₹163 Cr | +23.4% |
| Mar 2025 | ₹132 Cr | −71.7% |
| Dec 2024 | ₹467 Cr | +2.3% |
| Sep 2024 | ₹457 Cr | −18.1% |